Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Point of Care Testing of DOACs
NCT05491460Phase 1Unknown
- Sponsor
- Doasense
- Start
- Jul 2022
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 1, open-label trial (4 arms), sponsored by Doasense. Primary endpoint: Accuracy and specificity of the DOAC Dipstick compare to LC-MSMS up to 6 months. Status: unknown.
Beyond the preview
Go deeper on NCT05491460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05491460.